Weight loss relies on a precise physiological mechanism: the caloric deficit, meaning energy expenditure exceeds intake. This principle remains the foundation of any effective approach. What has changed today are the tools available to achieve this without compromising health or causing the rebound effect that most restrictive diets lead to.
GLP-1 Agonists and Weight Loss: A Long-Term Treatment
Treatments with GLP-1 receptor agonists (such as semaglutide) and dual GLP-1/GIP agonists (such as tirzepatide) represent the most significant pharmacological advancement in the management of obesity. These molecules act on the satiety hormones produced by the intestine, markedly reducing appetite.
A often underestimated point: these medications do not work as a one-time cure. Data from the STEP clinical program show a significant weight regain after stopping treatment, while maintaining treatment for two years allows for a loss of about 15%. Stopping treatment leads to regaining most of the lost weight.
This means that these treatments should be considered over the long term, integrated into a structured program that includes nutritional follow-up and behavioral support. The French Academy of Medicine also recommends prescribing them within this comprehensive framework, rather than in isolation. To explore the various weight loss approaches available, you can visit the MS Medical website to compare the devices suited to each profile.
European Consensus 2026: Nutrition and Psychology at the Center of the Weight Loss Journey
In July 2026, a European expert consensus published jointly by EASO, EFAD, and ECPO established a precise framework for monitoring patients undergoing incretin-based treatments. This document is not limited to medication prescription.
It emphasizes three complementary pillars:
- A personalized dietary follow-up to prevent deficiencies related to the drastic reduction in appetite caused by these molecules
- A psychological support targeting compulsive eating behaviors and the emotional relationship with food
- A regular reassessment of weight goals, adjusted to the patient’s metabolic profile rather than an arbitrary BMI
This consensus marks a turning point in the approach to obesity in Europe. It recognizes that sustainable weight loss requires a care ecosystem, not just a medication or an isolated diet.
Digital Therapies and Online Programs: Measured Results
Beyond pharmacology, digital therapies are emerging as a concrete complementary tool. In France, devices like Wellapy offer structured support via a mobile app, combining dietary tracking, behavioral therapy exercises, and regular coaching.
A randomized clinical trial conducted in Mexico demonstrated that an online weight loss program with remote monitoring produced significant results in overweight adults. These results suggest that easier access to follow-up (without travel, with automated reminders) improves adherence to the program over several months.
The value of these solutions lies in their ability to maintain regular contact with the patient between medical consultations. The regularity of follow-up is as important as the nature of the diet. A patient who receives weekly feedback on their habits is more likely to maintain their efforts than a patient seen every three months.
Nutrition and Natural Products: What Works Beyond Trends
The role of nutrition in weight loss is not limited to calorie counting. The quality of the foods consumed directly influences satiety, metabolism, and body composition.
Three dietary levers deserve particular attention:
- Proteins at every meal: they increase the energy expenditure related to digestion and preserve muscle mass during the caloric deficit
- Soluble fibers (legumes, oats, fruits): they slow carbohydrate absorption and prolong the feeling of fullness
- Reduction of ultra-processed products: in August 2026, French retail announced commitments to reduce salt, sugar, and colorants in its store brands, indicating progress in reformulating food products
Plants often cited in natural weight loss solutions (green tea, guarana, konjac) may offer modest support, but none replace a controlled caloric deficit. Their effectiveness remains conditioned on a holistic lifestyle including regular exercise and stress management.
The Ignored Balance Weight Trap
Every body has a balance weight determined by genetics, physical activity level, and individual metabolism. Aiming for a weight far from this natural threshold significantly increases the risk of regaining weight. Diets that promise spectacular losses in a few weeks ignore this biological reality, which explains their high long-term failure rate.
Sustainable approaches accept this parameter and work with the body rather than against it. A moderate deficit maintained over several months produces more stable results than severe restriction followed by a return to old habits.
Sustainable weight loss in 2026 relies on a combination of structured pharmacological treatments, regular digital follow-up, and a rethought diet centered around food quality. The recent European consensus confirms that medication alone is not enough without nutritional and behavioral support. Each journey remains individual, and the choice of tools depends on the metabolic profile, history, and realistic goals of each person.
